Nearly 60 percent of new entrants to the Medicare Advantage market are provider-sponsored health plans, according to a new report from Avalere Health.
Federal regulators have banned Cigna from selling new Medicare products because of issues with its Part C and Part D plans that increased enrollees' out-of-pocket expenses which led to delays or denials in receiving medical services and prescription drugs.
The Centers for Medicare & Medicaid Services underpaid Medicare Advantage health plans for the costs of treating individuals with multiple chronic conditions, according to a new analysis from Avalere Health.
Humana is expected to record financial and membership losses tied to its Affordable Care Act plans, according to a new filing with the U.S. Securities and Exchange Commission, though the insurance giant does expect gains in Medicare Advantage.
Though Medicare Advantage plans are not included in the federal government's goal to transition Medicare to a value-based payment system, they should be, according to a recent Health Affairs blog post.
The Centers for Medicare & Medicaid Services knew as far back as 2008 that certain Medicare Advantage plans were pocketing billions in overpayments, but officials still held back on auditing the plans and recouping payments tied to inflated risk scores, according to government records obtained by the Center for Public Integrity.
In their first year of working together, a Pennsylvania accountable care organization and Humana have been able to improve health measures among Medicare Advantage members.
The government's proposed changes to its risk-adjustment model for Medicare Advantage plans could result in large payment increases and decreases depending on where seniors live, according to an analysis by Avalere Health.
HouseCalls, a program that sends a physician or a nurse practitioner to on a home visit to Medicare Advantage members, cut both hospital and nursing home admissions, according to a new study.
Medicare Advantage plan choices are changing in 2016, and these changes include plan availability, premium costs, drug price deductibles and satisfaction ratings, according to a new report from the Kaiser Family Foundation.